Ya-Fang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ya-Fang Chen has a total of 372 co-authors. Here are the top co-authors by number of shared publications:
- Hon-Man Liu
Medical Imaging, Fu Jen Catholic University College of Medicine, New Taipei City, Taiwan
36 shared publications - Chung-Wei Lee
Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan
21 shared publications - Ming-Jang Chiu
Department of Neurology, National Taiwan University Hospital, College of Medicine
15 shared publications - Jiann-Shing Jeng
National Taiwan University Hospital
14 shared publications - Ta-Fu Chen
Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan
13 shared publications Sung-Chun Tang
Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan
9 shared publications
Latest Publications
- 16 October 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
Unilateral vs bilateral hippocampal avoidance during whole-brain radiotherapy with memantine for brain metastases: A randomized single-blind phase 2 clinical trial
Background: Hippocampal avoidance whole-brain radiotherapy (HA-WBRT) with memantine reduces, but does not eliminate, cognitive decline. Left hippocampal dose may be more closely associated with cognitive outcomes. We investigated whether unilateral (left) HA-WBRT is equivalent to bilateral HA-WBRT for neurocognitive function. Methods: In this randomized, single-blind, phase 2 equivalence trial, patients with brain metastases were assigned 1:1 to unilateral (left) or bilateral HA-WBRT (30 Gy in 10 fractions) with concurrent memantine. The primary endpoint was relative decline in Hopkins Verbal Learning Test-Revised (HVLT-R) memory score from baseline to 6 months; equivalence required the 90% CI for the between-arm difference to fall within ±15 percentage points. Results: Among 73 patients (unilateral, n = 36; bilateral, n = 37; median follow-up, 13.2 months), mean 6-month relative HVLT-R decline was 4.75% versus 5.05% (difference, −0.31 percentage points; 90% CI, −12.02 to 11.40 percentage points; TOST P = .02), meeting the equivalence criterion. Brain progression-free survival (10.3 vs 10.8 months; P = .96), overall survival (17.8 vs 12.8 months; P = .94), acute toxicity (≥grade 2, 44.4% vs 35.1%; P = .43), and 6-month neurocognitive failure (61.1% vs 56.8%; Gray test P = .78) were similar. Global health status appeared more stable with unilateral HA-WBRT (interaction, P < .001). Exploratory plasma brain-derived neurotrophic factor (BDNF) trajectories varied by neurocognitive failure status (FDR q = .09). Conclusions: Unilateral (left) HA-WBRT with memantine met the prespecified equivalence criterion for verbal memory, with comparable oncologic outcomes and safety; non-verbal memory was not assessed. These findings warrant validation, particularly when bilateral avoidance is challenging.
- 16 October 2026
- Published by Oxford University Press (OUP) in Neuro-Oncology
Unilateral vs bilateral hippocampal avoidance during whole-brain radiotherapy with memantine for brain metastases: A randomized single-blind phase 2 clinical trial
Background: Hippocampal avoidance whole-brain radiotherapy (HA-WBRT) with memantine reduces, but does not eliminate, cognitive decline. Left hippocampal dose may be more closely associated with cognitive outcomes. We investigated whether unilateral (left) HA-WBRT is equivalent to bilateral HA-WBRT for neurocognitive function. Methods: In this randomized, single-blind, phase 2 equivalence trial, patients with brain metastases were assigned 1:1 to unilateral (left) or bilateral HA-WBRT (30 Gy in 10 fractions) with concurrent memantine. The primary endpoint was relative decline in Hopkins Verbal Learning Test-Revised (HVLT-R) memory score from baseline to 6 months; equivalence required the 90% CI for the between-arm difference to fall within ±15 percentage points. Results: Among 73 patients (unilateral, n = 36; bilateral, n = 37; median follow-up, 13.2 months), mean 6-month relative HVLT-R decline was 4.75% versus 5.05% (difference, −0.31 percentage points; 90% CI, −12.02 to 11.40 percentage points; TOST P = .02), meeting the equivalence criterion. Brain progression-free survival (10.3 vs 10.8 months; P = .96), overall survival (17.8 vs 12.8 months; P = .94), acute toxicity (≥grade 2, 44.4% vs 35.1%; P = .43), and 6-month neurocognitive failure (61.1% vs 56.8%; Gray test P = .78) were similar. Global health status appeared more stable with unilateral HA-WBRT (interaction, P < .001). Exploratory plasma brain-derived neurotrophic factor (BDNF) trajectories varied by neurocognitive failure status (FDR q = .09). Conclusions: Unilateral (left) HA-WBRT with memantine met the prespecified equivalence criterion for verbal memory, with comparable oncologic outcomes and safety; non-verbal memory was not assessed. These findings warrant validation, particularly when bilateral avoidance is challenging.
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 11 (5)
Vascular NOTCH3 Deposition Load
Vascular NOTCH3 extracellular domain (NOTCH3ECD) deposition is the pathologic hallmark of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We aimed to explore the relationships among the NOTCH3ECD deposition load, the NOTCH3 variant genotype, and cerebral small vessel disease (SVD) severity. Fifty-four individuals carrying NOTCH3 pathogenic variants were enrolled and underwent skin biopsy for the quantification of dermal vascular NOTCH3ECD deposition load using immunohistochemical staining. The NOTCH3ECD deposition load, defined as the percentage of the NOTCH3ECD-stained area within the vessel area marked by smooth muscle actin staining, was compared among NOTCH3 p.R544C heterozygotes (n = 46), p.R544C homozygotes (n = 3), and individuals with pathogenic variants in epidermal growth factor-like repeats (EGFr) 1–6 and 8 (n = 5). In NOTCH3 p.R544C heterozygotes, we further investigated the associations between the NOTCH3ECD deposition load and various clinical and imaging severity measures of cerebral SVD using regression models adjusted for age, sex, and hypertension. The NOTCH3ECD deposition load was greater in individuals with NOTCH3 variants located in EGFr 1–6 and 8 (93.21%) and in p.R544C homozygotes (56.63%) than in p.R544C heterozygotes (16.37%, p = 0.0004 and 0.0296, respectively). In NOTCH3 p.R544C heterozygotes, no statistically significant associations were found between NOTCH3ECD load and disease severity stage, stroke incidence, Mini-Mental State Examination score, or functional independence. Regarding MRI features, a greater NOTCH3ECD load was associated with an increased cerebral microbleed count (B = 0.074, 95% CI = 0.014–0.135, p = 0.018) but was not associated with white matter hyperintensity burden, lacune count, or brain parenchymal fraction after adjustment for age, sex, and hypertension. The NOTCH3 variant genotype is a key determinant of the vascular NOTCH3ECD deposition load. The weak association between CADASIL disease severity and NOTCH3ECD deposition load suggests the importance of modifying factors that contribute to the diverse clinical spectrum of NOTCH3 vasculopathy.
- 1 October 2025
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 11 (5)
Open AccessVascular NOTCH3 Deposition Load
Vascular NOTCH3 extracellular domain (NOTCH3ECD) deposition is the pathologic hallmark of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). We aimed to explore the relationships among the NOTCH3ECD deposition load, the NOTCH3 variant genotype, and cerebral small vessel disease (SVD) severity. Fifty-four individuals carrying NOTCH3 pathogenic variants were enrolled and underwent skin biopsy for the quantification of dermal vascular NOTCH3ECD deposition load using immunohistochemical staining. The NOTCH3ECD deposition load, defined as the percentage of the NOTCH3ECD-stained area within the vessel area marked by smooth muscle actin staining, was compared among NOTCH3 p.R544C heterozygotes (n = 46), p.R544C homozygotes (n = 3), and individuals with pathogenic variants in epidermal growth factor-like repeats (EGFr) 1–6 and 8 (n = 5). In NOTCH3 p.R544C heterozygotes, we further investigated the associations between the NOTCH3ECD deposition load and various clinical and imaging severity measures of cerebral SVD using regression models adjusted for age, sex, and hypertension. The NOTCH3ECD deposition load was greater in individuals with NOTCH3 variants located in EGFr 1–6 and 8 (93.21%) and in p.R544C homozygotes (56.63%) than in p.R544C heterozygotes (16.37%, p = 0.0004 and 0.0296, respectively). In NOTCH3 p.R544C heterozygotes, no statistically significant associations were found between NOTCH3ECD load and disease severity stage, stroke incidence, Mini-Mental State Examination score, or functional independence. Regarding MRI features, a greater NOTCH3ECD load was associated with an increased cerebral microbleed count (B = 0.074, 95% CI = 0.014–0.135, p = 0.018) but was not associated with white matter hyperintensity burden, lacune count, or brain parenchymal fraction after adjustment for age, sex, and hypertension. The NOTCH3 variant genotype is a key determinant of the vascular NOTCH3ECD deposition load. The weak association between CADASIL disease severity and NOTCH3ECD deposition load suggests the importance of modifying factors that contribute to the diverse clinical spectrum of NOTCH3 vasculopathy.
- Open Access
- 5 September 2025
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 12 (12) , 2433-2445
Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease
Objective: Neuroinflammation driven by extracellular copper contributes to neuronal damage in Wilson's disease (WD). This study investigated the relationship between brain metal burden and peripheral neuroinflammation markers in WD. Methods: We conducted a cross‐sectional study involving 89 participants, including patients with WD ( n = 63), asymptomatic ATP7B heterozygous carriers ( n = 12), and age/sex‐matched controls ( n = 14). Brain metal burden was assessed using quantitative susceptibility mapping (QSM) MRI. Plasma glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) levels were measured. Clinical severity was evaluated using the mini–Unified Wilson's Disease Rating Scale (UWDRS) and Montreal Cognitive Assessment (MoCA). The influence of copper chelation treatment on biomarker correlations was also examined. Results: Patients with WD had a significantly higher level of GFAP ( p = 0.02) and brain metal burden ( p < 0.01) than the control group. Plasma NfL levels were marginally elevated in the WD group ( p = 0.07). Notably, elevated plasma GFAP levels were significantly associated with higher UWDRS scores ( r = 0.35, p < 0.01) and lower MoCA scores ( r = −0.36, p < 0.01). The NfL levels were also correlated with UWDRS ( r = 0.58, p < 0.01) and marginally correlated with MoCA ( r = −0.32, p = 0.02). The brain magnetic susceptibility value was positively correlated with increased plasma GFAP level, particularly in the putamen ( p < 0.001), which was more prominent in WD patients without chelating agent treatment ( r = 0.58, p < 0.001). Interpretations: Plasma GFAP levels reflect both clinical severity and brain metal accumulation in WD, with this association influenced by copper chelation therapy.
- 5 September 2025
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 12 (12) , 2433-2445
Open AccessPlasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease
Objective: Neuroinflammation driven by extracellular copper contributes to neuronal damage in Wilson's disease (WD). This study investigated the relationship between brain metal burden and peripheral neuroinflammation markers in WD. Methods: We conducted a cross‐sectional study involving 89 participants, including patients with WD ( n = 63), asymptomatic ATP7B heterozygous carriers ( n = 12), and age/sex‐matched controls ( n = 14). Brain metal burden was assessed using quantitative susceptibility mapping (QSM) MRI. Plasma glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) levels were measured. Clinical severity was evaluated using the mini–Unified Wilson's Disease Rating Scale (UWDRS) and Montreal Cognitive Assessment (MoCA). The influence of copper chelation treatment on biomarker correlations was also examined. Results: Patients with WD had a significantly higher level of GFAP ( p = 0.02) and brain metal burden ( p < 0.01) than the control group. Plasma NfL levels were marginally elevated in the WD group ( p = 0.07). Notably, elevated plasma GFAP levels were significantly associated with higher UWDRS scores ( r = 0.35, p < 0.01) and lower MoCA scores ( r = −0.36, p < 0.01). The NfL levels were also correlated with UWDRS ( r = 0.58, p < 0.01) and marginally correlated with MoCA ( r = −0.32, p = 0.02). The brain magnetic susceptibility value was positively correlated with increased plasma GFAP level, particularly in the putamen ( p < 0.001), which was more prominent in WD patients without chelating agent treatment ( r = 0.58, p < 0.001). Interpretations: Plasma GFAP levels reflect both clinical severity and brain metal accumulation in WD, with this association influenced by copper chelation therapy.
- 1 June 2025
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 11 (3) , e200258
Prevalence and Characteristics of Pathogenic Variants in Taiwanese Patients With Cerebral Small Vessel Disease
The Taiwan-Associated Genetic and Non-genetic Small Vessel Disease (TAG-SVD) cohort prospectively enrolls patients with cerebral small vessel disease (SVD). The aim of this study was to determine the prevalence and characteristics of monogenic SVD in patients within the TAG-SVD cohort. All patients in the TAG-SVD cohort underwent initial screening for NOTCH3 p.R544C variant, which is the hotspot disease-causing variant in Taiwan. Those who tested negative for NOTCH3 p.R544C variant underwent next-generation sequencing targeting 5 candidate SVD genes: NOTCH3, HTRA1, GLA, TREX1, and COL4A1. Clinical and neuroimaging features were compared between the genetic and nongenetic groups, as well as between specific pathogenic variants in NOTCH3 and HTRA1. A total of 1,086 patients (mean age 62.9 ± 12.4 years, 61% male) were enrolled. Disease-causing variants in the candidate genes were identified in 284 patients (26.2%), including 244 with the NOTCH3 p.R544C variants, 12 with NOTCH3 variants in EGFr 7-34 outside the p.R544C hotspot, 11 with NOTCH3 variants in EGFr 1-6, 9 with HTRA1, 5 with TREX1, 2 with COL4A1, and 1 with a GLA pathogenic variant. Compared with those with nongenetic SVD, individuals with monogenic SVD were more likely to be female, exhibited a higher familial stroke history, had lower rates of hypertension and diabetes, and experienced fewer previous strokes. They also displayed more severe white matter hyperintensity (WMH) and a higher prevalence of anterior temporal and external capsule WMH involvement on MRI. Patients with HTRA1 pathogenic variants had similar ages at genetic diagnosis, ages at stroke, and WMH severity compared with those with NOTCH3 pathogenic variants in EGFr 7-34. However, they had a later age at onset and milder severity compared with those with NOTCH3 pathogenic variants in EGFr 1-6. Anterior temporal WMH involvement was most pronounced in patients with NOTCH3 EGFr 1-6 (82%), less in NOTCH3 EGFr 7-34 (33%), and absent in those with HTRA1 pathogenic variants. Monogenic disease-causing variants are relatively common in Taiwanese patients with SVD, particularly the NOTCH3 p.R544C variants. HTRA1 variants exhibited similar clinical and imaging features to NOTCH3 EGFr 7-34 variants, but without anterior temporal WMH involvement. These findings underscore the importance of genetic screening to understand SVD heterogeneity and guide personalized management.
- 1 June 2025
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 11 (3) , e200258
Prevalence and Characteristics of Pathogenic Variants in Taiwanese Patients With Cerebral Small Vessel Disease
The Taiwan-Associated Genetic and Non-genetic Small Vessel Disease (TAG-SVD) cohort prospectively enrolls patients with cerebral small vessel disease (SVD). The aim of this study was to determine the prevalence and characteristics of monogenic SVD in patients within the TAG-SVD cohort. All patients in the TAG-SVD cohort underwent initial screening for NOTCH3 p.R544C variant, which is the hotspot disease-causing variant in Taiwan. Those who tested negative for NOTCH3 p.R544C variant underwent next-generation sequencing targeting 5 candidate SVD genes: NOTCH3, HTRA1, GLA, TREX1, and COL4A1. Clinical and neuroimaging features were compared between the genetic and nongenetic groups, as well as between specific pathogenic variants in NOTCH3 and HTRA1. A total of 1,086 patients (mean age 62.9 ± 12.4 years, 61% male) were enrolled. Disease-causing variants in the candidate genes were identified in 284 patients (26.2%), including 244 with the NOTCH3 p.R544C variants, 12 with NOTCH3 variants in EGFr 7-34 outside the p.R544C hotspot, 11 with NOTCH3 variants in EGFr 1-6, 9 with HTRA1, 5 with TREX1, 2 with COL4A1, and 1 with a GLA pathogenic variant. Compared with those with nongenetic SVD, individuals with monogenic SVD were more likely to be female, exhibited a higher familial stroke history, had lower rates of hypertension and diabetes, and experienced fewer previous strokes. They also displayed more severe white matter hyperintensity (WMH) and a higher prevalence of anterior temporal and external capsule WMH involvement on MRI. Patients with HTRA1 pathogenic variants had similar ages at genetic diagnosis, ages at stroke, and WMH severity compared with those with NOTCH3 pathogenic variants in EGFr 7-34. However, they had a later age at onset and milder severity compared with those with NOTCH3 pathogenic variants in EGFr 1-6. Anterior temporal WMH involvement was most pronounced in patients with NOTCH3 EGFr 1-6 (82%), less in NOTCH3 EGFr 7-34 (33%), and absent in those with HTRA1 pathogenic variants. Monogenic disease-causing variants are relatively common in Taiwanese patients with SVD, particularly the NOTCH3 p.R544C variants. HTRA1 variants exhibited similar clinical and imaging features to NOTCH3 EGFr 7-34 variants, but without anterior temporal WMH involvement. These findings underscore the importance of genetic screening to understand SVD heterogeneity and guide personalized management.
- Open Access
- 21 April 2025
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 125 (7) , 815-822
Unveiling the characteristics of lobar-predominant cerebral microbleeds in Fabry disease
- 21 April 2025
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 125 (7) , 815-822
Open AccessUnveiling the characteristics of lobar-predominant cerebral microbleeds in Fabry disease
- 24 February 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (8) , 1632-1639
Comparison of Prophylactic Endovascular Treatments for Threatened or Impending Internal/Common Carotid Artery Blowout Syndrome
BACKGROUND AND PURPOSE: The outcomes of prophylactic endovascular interventions for patients facing threatened or impending carotid blowout syndrome (CBS) involving the internal/common carotid artery (ICA/CCA) have not been extensively elucidated. We aimed to delineate the specific treatment outcomes for this group of patients. MATERIALS AND METHODS: We retrospectively enrolled 109 patients with threatened or impending CBS of the ICA/CCA between 2006 and 2023. Patients were categorized into Group 1 (no intervention for ICA/CCA, n=43), Group 2 (ICA/CCA embolization, n=36), or Group 3 (ICA/CCA stenting, n=30). ANOVA and Cox regression analyses were employed to evaluate basic characteristics and the rates of recurrent bleeding, overall survival, and major complications. RESULTS: Age (56.8 ± 8.7 vs. 54.3 ± 11.6 vs. 56.6 ± 9.2), male sex (39/43 vs. 33/36 vs. 26/30), tumor size, and type of blowout were similar (P>0.05) among groups. Tumor location (P<0.001) and presence of air-containing necrosis on CT/MRI before trans-arterial embolization (P=0.001) varied between groups. Cox regression analysis adjusted for age and sex revealed Group 2 had a lower risk of recurrent bleeding than Group 1 (adjusted hazard ratio (HR), 0.22; 95% CI, 0.10–0.47; P<0.001) and Group 3 (0.41; 95% CI, 0.170.96; P=0.042), but a higher risk of acute stroke (P=0.016). Group 2 had higher overall survival than Groups 1 and 3 (0.55; 95% CI, 0.31–0.96; P=0.036). CONCLUSIONS: In threatened or impending CBS of the ICA/CCA, prophylactic embolization was associated with a lower risk of recurrent bleeding but a higher risk of acute stroke compared to ICA/CCA stenting or no intervention. ABBREVIATIONS: BTO = balloon test occlusion; CBS = carotid blowout syndrome; CCA = common carotid artery; ECA = external carotid artery; HR = hazard ratio; ICA = internal carotid artery; TAE = trans-arterial embolization.
- 24 February 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 46 (8) , 1632-1639
Comparison of Prophylactic Endovascular Treatments for Threatened or Impending Internal/Common Carotid Artery Blowout Syndrome
BACKGROUND AND PURPOSE: The outcomes of prophylactic endovascular interventions for patients facing threatened or impending carotid blowout syndrome (CBS) involving the internal/common carotid artery (ICA/CCA) have not been extensively elucidated. We aimed to delineate the specific treatment outcomes for this group of patients. MATERIALS AND METHODS: We retrospectively enrolled 109 patients with threatened or impending CBS of the ICA/CCA between 2006 and 2023. Patients were categorized into Group 1 (no intervention for ICA/CCA, n=43), Group 2 (ICA/CCA embolization, n=36), or Group 3 (ICA/CCA stenting, n=30). ANOVA and Cox regression analyses were employed to evaluate basic characteristics and the rates of recurrent bleeding, overall survival, and major complications. RESULTS: Age (56.8 ± 8.7 vs. 54.3 ± 11.6 vs. 56.6 ± 9.2), male sex (39/43 vs. 33/36 vs. 26/30), tumor size, and type of blowout were similar (P>0.05) among groups. Tumor location (P<0.001) and presence of air-containing necrosis on CT/MRI before trans-arterial embolization (P=0.001) varied between groups. Cox regression analysis adjusted for age and sex revealed Group 2 had a lower risk of recurrent bleeding than Group 1 (adjusted hazard ratio (HR), 0.22; 95% CI, 0.10–0.47; P<0.001) and Group 3 (0.41; 95% CI, 0.170.96; P=0.042), but a higher risk of acute stroke (P=0.016). Group 2 had higher overall survival than Groups 1 and 3 (0.55; 95% CI, 0.31–0.96; P=0.036). CONCLUSIONS: In threatened or impending CBS of the ICA/CCA, prophylactic embolization was associated with a lower risk of recurrent bleeding but a higher risk of acute stroke compared to ICA/CCA stenting or no intervention. ABBREVIATIONS: BTO = balloon test occlusion; CBS = carotid blowout syndrome; CCA = common carotid artery; ECA = external carotid artery; HR = hazard ratio; ICA = internal carotid artery; TAE = trans-arterial embolization.
- Open Access
- 3 September 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 91, 105856
Comparing the imaging characteristics of middle-aged patients with multiple sclerosis and CADASIL: A retrospective cross-sectional study
- 3 September 2024
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 91, 105856
Open AccessComparing the imaging characteristics of middle-aged patients with multiple sclerosis and CADASIL: A retrospective cross-sectional study
- 23 April 2024
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 47 (7) , 955-961
The Clinical Outcome of Carotid Blowout Syndrome Showing Non-bleeding Angiography
Objective Patient with carotid blowout syndrome (CBS) may demonstrated non-bleeding digital subtraction angiography (DSA) without identifying pseudoaneurysm or contrast extravasation. Our objective is to evaluate the clinical outcomes for this specific subset of patients. Materials and Methods A retrospective observational study was conducted on 172 CBS patients who received DSA for evaluation of transarterial embolization (TAE) between 2005 and 2022, of whom 19 patients had non-bleeding DSA and did not undergo TAE. Results The age (55.2 ± 7.3 vs. 54.8 ± 11.1), male sex (17/19 vs. 135/153), tumor size (5.6 ± 2.4 vs. 5.2 ± 2.2), cancer locations were similar (P > 0.05) between both groups; except for there were more pseudoaneurysm/active bleeding (85.6% vs. 0%) and less vascular irregularity (14.4% vs. 94.7%) in the TAE group (P < 0.001). In the multivariable Cox regression model adjusting for age, sex, and tumor size, non-bleeding DSA group was independently associated with recurrent bleeding compared to TAE group (adjusted hazard ratio = 3.5, 95% confidence interval: 1.9–6.4, P < 0.001). Furthermore, the presence of vascular irregularity was associated with segmental recurrent bleeding (adjusted HR = 8.0, 95% CI 2.7–23.3, P < 0.001). Conclusion Patient showing non-bleeding DSA thus not having TAE had higher risk of recurrent bleeding, compared to patient who received TAE. Level of Evidence Level 4, Case Series.
- 23 April 2024
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 47 (7) , 955-961
The Clinical Outcome of Carotid Blowout Syndrome Showing Non-bleeding Angiography
Objective Patient with carotid blowout syndrome (CBS) may demonstrated non-bleeding digital subtraction angiography (DSA) without identifying pseudoaneurysm or contrast extravasation. Our objective is to evaluate the clinical outcomes for this specific subset of patients. Materials and Methods A retrospective observational study was conducted on 172 CBS patients who received DSA for evaluation of transarterial embolization (TAE) between 2005 and 2022, of whom 19 patients had non-bleeding DSA and did not undergo TAE. Results The age (55.2 ± 7.3 vs. 54.8 ± 11.1), male sex (17/19 vs. 135/153), tumor size (5.6 ± 2.4 vs. 5.2 ± 2.2), cancer locations were similar (P > 0.05) between both groups; except for there were more pseudoaneurysm/active bleeding (85.6% vs. 0%) and less vascular irregularity (14.4% vs. 94.7%) in the TAE group (P < 0.001). In the multivariable Cox regression model adjusting for age, sex, and tumor size, non-bleeding DSA group was independently associated with recurrent bleeding compared to TAE group (adjusted hazard ratio = 3.5, 95% confidence interval: 1.9–6.4, P < 0.001). Furthermore, the presence of vascular irregularity was associated with segmental recurrent bleeding (adjusted HR = 8.0, 95% CI 2.7–23.3, P < 0.001). Conclusion Patient showing non-bleeding DSA thus not having TAE had higher risk of recurrent bleeding, compared to patient who received TAE. Level of Evidence Level 4, Case Series.
- Open Access
- 22 July 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (11) , 1882-1891.e1
The Extent of Tumor Invasion and Therapeutic Embolization Are Associated with Recurrent Hemorrhage in Patients with External Carotid Artery Blowout Syndrome
- 22 July 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (11) , 1882-1891.e1
Open AccessThe Extent of Tumor Invasion and Therapeutic Embolization Are Associated with Recurrent Hemorrhage in Patients with External Carotid Artery Blowout Syndrome
- Open Access
- 20 June 2023
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 10 (8) , 1456-1466
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration
Objective: This study aimed to explore the clinical significance of brain imaging signatures in the context of clinical neurological deficits in association with upper and lower motor neuron degeneration in amyotrophic lateral sclerosis (ALS).Methods: We performed brain MRI examinations to quantitatively evaluate (1) gray matter volume and (2) white matter tract fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD). Image‐derived indices were correlated with (1) global neurological deficits of MRC muscle strength sum score, revised amyotrophic lateral sclerosis functional rating scale (ALSFRS‐R), and forced vital capacity (FVC), and (2) focal scores of University of Pennsylvania Upper motor neuron score (Penn score) and the summation of compound muscle action potential Z scores (CMAP Z sum score).Results: There were 39 ALS patients and 32 control subjects matched for age and gender. Compared to controls, ALS patients had a lower gray matter volume in the precentral gyrus of the primary motor cortex, which was correlated with FA of corticofugal tracts. The gray matter volume of the precentral gyrus was correlated with FVC, MRC sum score, and CMAP Z sum score, while the FA of the corticospinal tract was linearly associated with CMAP Z sum score and Penn score on multivariate linear regression model.Interpretation: This study indicated that clinical assessment of muscle strength and routine measurements on nerve conduction studies provided surrogate markers of brain structural changes for ALS. Furthermore, these findings suggested parallel involvement of both upper and lower motor neurons in ALS.
- 20 June 2023
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 10 (8) , 1456-1466
Open AccessBrain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration
Objective: This study aimed to explore the clinical significance of brain imaging signatures in the context of clinical neurological deficits in association with upper and lower motor neuron degeneration in amyotrophic lateral sclerosis (ALS).Methods: We performed brain MRI examinations to quantitatively evaluate (1) gray matter volume and (2) white matter tract fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD). Image‐derived indices were correlated with (1) global neurological deficits of MRC muscle strength sum score, revised amyotrophic lateral sclerosis functional rating scale (ALSFRS‐R), and forced vital capacity (FVC), and (2) focal scores of University of Pennsylvania Upper motor neuron score (Penn score) and the summation of compound muscle action potential Z scores (CMAP Z sum score).Results: There were 39 ALS patients and 32 control subjects matched for age and gender. Compared to controls, ALS patients had a lower gray matter volume in the precentral gyrus of the primary motor cortex, which was correlated with FA of corticofugal tracts. The gray matter volume of the precentral gyrus was correlated with FVC, MRC sum score, and CMAP Z sum score, while the FA of the corticospinal tract was linearly associated with CMAP Z sum score and Penn score on multivariate linear regression model.Interpretation: This study indicated that clinical assessment of muscle strength and routine measurements on nerve conduction studies provided surrogate markers of brain structural changes for ALS. Furthermore, these findings suggested parallel involvement of both upper and lower motor neurons in ALS.